Skip to main content

Table 3 The KEGG pathways significantly enriched for target genes of deregulated miRNAs in the atrial myocardial tissue from patients with CHD after CPB (n = 3) compared to before CPB (n = 3) ( P value < 0.05)

From: Differential expression of microRNAs following cardiopulmonary bypass in children with congenital heart diseases

Mode of interaction

KEGG pathway

P-value

No. genes

No. miRNAs

Signaling transduction

Hippo signaling pathway

1.11E + 05

114

70

Phosphatidylinositol signaling system

1.23E + 06

66

63

TGF-beta signaling pathway

3.29E + 06

64

53

cGMP-PKG signaling pathway

3.29E + 06

128

74

FoxO signaling pathway

0.001

98

72

ErbB signaling pathway

0.0027

67

62

MAPK signaling pathway

0.003

179

77

Ras signaling pathway

0.0035

155

76

Sphingolipid signaling pathway

0.0145

85

64

Calcium signaling pathway

0.0174

124

71

AMPK signaling pathway

0.0189

86

67

cAMP signaling pathway

0.019

137

71

TNF signaling pathway

0.0229

76

63

Rap1 signaling pathway

0.0243

143

70

Cardiovascular diseases and Circulatory system

Adrenergic signaling in cardiomyocytes

1.20E + 06

112

71

Dilated cardiomyopathy

0.0154

65

57

Arrhythmogenic right ventricular cardiomyopathy (ARVC)

0.0174

53

54

Vascular smooth muscle contraction

0.0196

83

65

Cellular community

Adherens junction

3.20E − 03

56

58

Focal adhesion

0.0044

146

74

Gap junction

0.0106

65

61

Cell adhesion molecules (CAMs)

0.0248

98

68